Literature DB >> 24523346

Consuming a Western diet for two weeks suppresses fetal genes in mouse hearts.

Heidi M Medford1, Emily J Cox, Lindsey E Miller, Susan A Marsh.   

Abstract

Diets high in sugar and saturated fat (Western diet) contribute to obesity and pathophysiology of metabolic syndrome. A common physiological response to obesity is hypertension, which induces cardiac remodeling and hypertrophy. Hypertrophy is regulated at the level of chromatin by repressor element 1-silencing transcription factor (REST), and pathological hypertrophy is associated with reexpression of a fetal cardiac gene program. Reactivation of fetal genes is commonly observed in hypertension-induced hypertrophy; however, this response is blunted in diabetic hearts, partially due to upregulation of the posttranslational modification O-linked-β-N-acetylglucosamine (O-GlcNAc) to proteins by O-GlcNAc transferase (OGT). OGT and O-GlcNAc are found in chromatin-modifying complexes, but it is unknown whether they play a role in Western diet-induced hypertrophic remodeling. Therefore, we investigated the interactions between O-GlcNAc, OGT, and the fetal gene-regulating transcription factor complex REST/mammalian switch-independent 3A/histone deacetylase (HDAC). Five-week-old male C57BL/6 mice were fed a Western (n = 12) or control diet (n = 12) for 2 wk to examine the early hypertrophic response. Western diet-fed mice exhibited fasting hyperglycemia and increased body weight (P < 0.05). As expected for this short duration of feeding, cardiac hypertrophy was not yet evident. We found that REST is O-GlcNAcylated and physically interacts with OGT in mouse hearts. Western blot analysis showed that HDAC protein levels were not different between groups; however, relative to controls, Western diet hearts showed increased REST and decreased ANP and skeletal α-actin. Transcript levels of HDAC2 and cardiac α-actin were decreased in Western diet hearts. These data suggest that REST coordinates regulation of diet-induced hypertrophy at the level of chromatin.

Entities:  

Keywords:  O-GlcNAc; cardiac hypertrophy; chromatin; fetal genes

Mesh:

Substances:

Year:  2014        PMID: 24523346      PMCID: PMC4121485          DOI: 10.1152/ajpregu.00253.2013

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  26 in total

1.  Cardiac O-GlcNAcylation blunts autophagic signaling in the diabetic heart.

Authors:  Susan A Marsh; Pamela C Powell; Louis J Dell'italia; John C Chatham
Journal:  Life Sci       Date:  2012-06-20       Impact factor: 5.037

2.  Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates.

Authors:  Brooke D Lazarus; Dona C Love; John A Hanover
Journal:  Glycobiology       Date:  2006-01-23       Impact factor: 4.313

3.  Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code.

Authors:  Kaoru Sakabe; Zihao Wang; Gerald W Hart
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-02       Impact factor: 11.205

4.  Activation of the hexosamine biosynthesis pathway and protein O-GlcNAcylation modulate hypertrophic and cell signaling pathways in cardiomyocytes from diabetic mice.

Authors:  Susan A Marsh; Louis J Dell'Italia; John C Chatham
Journal:  Amino Acids       Date:  2010-07-30       Impact factor: 3.520

5.  Impact of Type 2 diabetes and aging on cardiomyocyte function and O-linked N-acetylglucosamine levels in the heart.

Authors:  Norbert Fülöp; Meredith M Mason; Kaushik Dutta; Peipei Wang; Amy J Davidoff; Richard B Marchase; John C Chatham
Journal:  Am J Physiol Cell Physiol       Date:  2006-11-29       Impact factor: 4.249

6.  Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.

Authors:  Chinmay M Trivedi; Yang Luo; Zhan Yin; Maozhen Zhang; Wenting Zhu; Tao Wang; Thomas Floss; Martin Goettlicher; Patricia Ruiz Noppinger; Wolfgang Wurst; Victor A Ferrari; Charles S Abrams; Peter J Gruber; Jonathan A Epstein
Journal:  Nat Med       Date:  2007-02-18       Impact factor: 53.440

7.  Profiling RE1/REST-mediated histone modifications in the human genome.

Authors:  Deyou Zheng; Keji Zhao; Mark F Mehler
Journal:  Genome Biol       Date:  2009-01-27       Impact factor: 13.583

Review 8.  Molecular regulation of cardiac hypertrophy.

Authors:  Sean P Barry; Sean M Davidson; Paul A Townsend
Journal:  Int J Biochem Cell Biol       Date:  2008-02-26       Impact factor: 5.085

9.  Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase.

Authors:  Rodrick P Taylor; Glendon J Parker; Mark W Hazel; Yudi Soesanto; William Fuller; Marla J Yazzie; Donald A McClain
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

10.  Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression.

Authors:  Xiaoyong Yang; Fengxue Zhang; Jeffrey E Kudlow
Journal:  Cell       Date:  2002-07-12       Impact factor: 41.582

View more
  4 in total

Review 1.  Protein O-GlcNAcylation and cardiovascular (patho)physiology.

Authors:  Susan A Marsh; Helen E Collins; John C Chatham
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

Review 2.  Nutrient regulation of gene expression by O-GlcNAcylation of chromatin.

Authors:  Stéphan Hardivillé; Gerald W Hart
Journal:  Curr Opin Chem Biol       Date:  2016-06-17       Impact factor: 8.822

Review 3.  The role of O-GlcNAc transferase in regulating the gene transcription of developing and failing hearts.

Authors:  Heidi M Medford; Susan A Marsh
Journal:  Future Cardiol       Date:  2014-11

Review 4.  O-GlcNAcylation and cardiovascular disease.

Authors:  JaLessa N Wright; Helen E Collins; Adam R Wende; John C Chatham
Journal:  Biochem Soc Trans       Date:  2017-04-15       Impact factor: 5.407

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.